Samrudh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 6.20 M
- Company Age 33 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 103.44 Cr
- Revenue Growth 11.55%
- Profit Growth 272.00%
- Ebitda 42.16%
- Net Worth 1.54%
- Total Assets -7.26%
About Samrudh Pharmaceuticals
Samrudh Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 May 1991 and has a history of 33 years and eight months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.20 M.
The company currently has active open charges totaling ₹103.44 Cr.
Alok Sheth, Manish Jain, Sharad Sheth, and One other member serve as directors at the Company.
Company Details
-
LocationMumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH1991PTC061667
-
Company No.
061667
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 1991
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Samrudh Pharmaceuticals Private Limited offer?
Samrudh Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Samrudh Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohan Jain | Managing Director | 26-Mar-2018 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manish Jain | Director | 08-Jan-2021 | Current |
Alok Sheth | Whole-Time Director | 01-Apr-1996 | Current |
Sharad Sheth | Whole-Time Director | 22-Apr-1992 | Current |
Financial Performance of Samrudh Pharmaceuticals.
Samrudh Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.55% increase. The company also saw a substantial improvement in profitability, with a 272% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Samrudh Pharmaceuticals?
In 2021, Samrudh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹103.44 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 103.17 Cr
- Sicom Ltd : 0.27 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
06 Jul 2012 | Bank Of India | ₹1.49 M | Open |
31 Aug 2010 | Bank Of India | ₹1.00 Cr | Open |
06 Jul 2009 | Bank Of India | ₹3.00 Cr | Open |
07 Aug 2008 | Bank Of India | ₹1.50 Cr | Open |
21 Oct 2004 | Bank Of India | ₹29.70 Cr | Open |
How Many Employees Work at Samrudh Pharmaceuticals?
Samrudh Pharmaceuticals has a workforce of 328 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrudh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrudh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.